冠状动脉计算机断层扫描血管造影与功能负荷试验在疑似冠状动脉疾病患者中的比较:系统评价与荟萃分析
该系统评价与荟萃分析纳入13项随机临床试验,共10 315例CCTA组和9777例功能负荷试验组患者,平均随访18个月。CCTA组与功能负荷试验组相比,死亡(1.0% vs 1.1%;RR 0.93;95%CI 0.71-1.21)和心脏住院(2.7% vs 2.7%;RR 0.98;95%CI 0.79-1.21)无统计学显著差异,但心肌梗死发生率降低(0.7% vs 1.1%;RR 0.71;95%CI 0.53-0.96)。CCTA组侵入性冠状动脉造影(11.7% vs 9.1%;RR 1.33;95%CI 1.12-1.59)和血运重建(7.2% vs 4.5%;RR 1.86;95%CI 1.43-2.43)显著增加,新诊断CAD及启动阿司匹林或他汀治疗也更常见。尽管存在这些差异,CCTA与死亡率或心脏住院减少无关。
要点
- 疑似冠心病患者中,CCTA组心肌梗死发生率0.7% vs 功能负荷试验组1.1%(RR 0.71;95%CI 0.53-0.96)。
- CCTA组侵入性冠状动脉造影11.7% vs 功能负荷试验组9.1%(RR 1.33;95%CI 1.12-1.59),血运重建7.2% vs 4.5%(RR 1.86;95%CI 1.43-2.43)。
- CCTA组与功能负荷试验组死亡(1.0% vs 1.1%;RR 0.93;95%CI 0.71-1.21)和心脏住院(2.7% vs 2.7%;RR 0.98;95%CI 0.79-1.21)无统计学显著差异。
- CCTA组更常新诊断CAD并启动阿司匹林或他汀治疗。
- 平均随访18个月,共纳入13项随机临床试验、10 315例CCTA组和9777例功能负荷试验组患者。
适用人群与场景
- 疑似冠状动脉疾病(CAD)的患者。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入13项随机临床试验,CCTA组10 315例,功能负荷试验组9777例,平均随访18个月。
- 主要终点:死亡(1.0% vs 1.1%;RR 0.93;95%CI 0.71-1.21)和心脏住院(2.7% vs 2.7%;RR 0.98;95%CI 0.79-1.21)两组无统计学显著差异。
- 心肌梗死:CCTA组0.7% vs 功能负荷试验组1.1%(RR 0.71;95%CI 0.53-0.96)。
- 侵入性冠状动脉造影:CCTA组11.7% vs 功能负荷试验组9.1%(RR 1.33;95%CI 1.12-1.59)。
- 冠状动脉血运重建:CCTA组7.2% vs 功能负荷试验组4.5%(RR 1.86;95%CI 1.43-2.43)。
- CCTA组更常新诊断CAD并启动阿司匹林或他汀治疗。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入随机临床试验。
- 分析遵循PRISMA声明,使用Cochrane协作网偏倚风险评估工具,采用Mantel-Haenszel法进行主要分析,随机效应模型计算汇总相对危险度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论:与功能负荷试验相比,CCTA与心肌梗死发生率降低相关,但侵入性冠状动脉造影、血运重建、CAD诊断及阿司匹林或他汀新处方增加;尽管存在这些差异,CCTA与死亡率或心脏住院减少无关。
指南或共识出处
- JAMA Internal Medicine
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Coronary computed tomography angiography (CCTA) is a new approach for the diagnosis of anatomical coronary artery disease (CAD), but it is unclear how CCTA performs compared with the standard approach of functional stress testing.
OBJECTIVE: To compare the clinical effectiveness of CCTA with that of functional stress testing for patients with suspected CAD.
DATA SOURCES: A systematic literature search was conducted in PubMed and MEDLINE for English-language randomized clinical trials of CCTA published from January 1, 2000, to July 10, 2016.
STUDY SELECTION: Researchers selected randomized clinical trials that compared a primary strategy of CCTA with that of functional stress testing for patients with suspected CAD and reported data on patient clinical events and changes in therapy.
DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data from and assessed the quality of the trials. This analysis followed the PRISMA statement for reporting systematic reviews and meta-analyses and used the Cochrane Collaboration's tool for assessing risk of bias in randomized trials. The Mantel-Haenszel method was used to conduct the primary analysis. Summary relative risks were calculated with a random-effects model.
MAIN OUTCOMES AND MEASURES: The outcomes of interest were all-cause mortality, cardiac hospitalization, myocardial infarction, invasive coronary angiography, coronary revascularization, new CAD diagnoses, and change in prescription for aspirin and statins.
RESULTS: Thirteen trials were included, with 10 315 patients in the CCTA arm and 9777 patients in the functional stress testing arm who were followed up for a mean duration of 18 months. There were no statistically significant differences between CCTA and functional stress testing in death (1.0% vs 1.1%; risk ratio [RR], 0.93; 95% CI, 0.71-1.21) or cardiac hospitalization (2.7% vs 2.7%; RR, 0.98; 95% CI, 0.79-1.21), but CCTA was associated with a reduction in the incidence of myocardial infarction (0.7% vs 1.1%; RR, 0.71; 95% CI, 0.53-0.96). Patients undergoing CCTA were significantly more likely to undergo invasive coronary angiography (11.7% vs 9.1%; RR, 1.33; 95% CI, 1.12-1.59) and revascularization (7.2% vs 4.5%; RR, 1.86; 95% CI, 1.43-2.43). They were also more likely to receive a diagnosis of new CAD and to have initiated aspirin or statin therapy.
CONCLUSIONS AND RELEVANCE: Compared with functional stress testing, CCTA is associated with a reduced incidence of myocardial infarction but an increased incidence of invasive coronary angiography, revascularization, CAD diagnoses, and new prescriptions for aspirin and statins. Despite these differences, CCTA is not associated with a reduction in mortality or cardiac hospitalizations.
参考来源
- Foy AJ, Dhruva SS, Peterson B, et al. Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis. JAMA Intern Med. 2017. PMID: 28973101. doi:10.1001/jamainternmed.2017.4772
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。